Jason Grillot

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jason Grillot

Heron Therapeutics, Inc. /De/ reported in an 8-K filed April 20, 2023 that Jason Grillot was appointed Vice President, Sales and Marketing, Acute Care, effective April 24, 2023.

“Additionally, effective April 24, 2023, Jason Grillot will join the Company as Vice President, Sales and Marketing, Acute Care.”

Heron Therapeutics, Inc. /De/ Form 8-K, filed April 20, 2023 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Research with Equibles

Turn this profile into a cited research brief

Start with a question tailored to the filings and events on this page, or connect Equibles financial data to ChatGPT or Claude.

Suggested question: “Summarize Jason Grillot's recent executive appointments or departures and cite the source filings.”

Use in your AI

Affiliation history

Recorded current and former roles; source labels appear when available.

Heron Therapeutics, Inc. /De/ (HRTX)
Proxy statement

2023-04-24–2023-05-01

Last confirmed by a filing; no departure on record

Company network

Recorded roles and call appearances connecting this person to public companies.

Heron Therapeutics, Inc. /De/

HRTX

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.

Executive change Appointed: Vice President, Sales and Marketing, Acute Care Heron Therapeutics, Inc. /De/ (HRTX)
2023-04-24